Citation Impact
Citing Papers
Recent advances in clinical practice: epidemiology of autoimmune liver diseases
2021
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Three-Dimensional Perfusion Bioreactor Culture Supports Differentiation of Human Fetal Liver Cells
2010
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
The effect of CTLA-4 A49G polymorphism on rheumatoid arthritis risk: a meta-analysis
2014
Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group
2012
Towards the creation of decellularized organ constructs using irreversible electroporation and active mechanical perfusion
2010
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
2011
Time Course of Primary Liver Cell Reorganization in Three-Dimensional High-Density Bioreactors for Extracorporeal Liver Support: An Immunohistochemical and Ultrastructural Study
2004
Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: A pilot study
2005
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
NF-κB signaling in inflammation
2017 Standout
Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation
2005
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
2016 Standout
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence
2006
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
Mechanisms of hepatic stellate cell activation
2017 Standout
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
2011 StandoutNobel
Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death
2008
Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
2009
Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b
2007
Antifibrotic Agents for Liver Disease
2005
Hepatitis B and Hepatitis C Viruses in Liver Transplantation
2004
Outcomes of patients with hepatitis C undergoing simultaneous liver–kidney transplantation
2009
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
Clinical Benefits of Antiviral Therapy in Patients with Recurrent Hepatitis C Following Liver Transplantation
2008
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
2012
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation
2006
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Fibrosis progression after liver transplantation in patients with recurrent hepatitis C
2004
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
An overview of tissue and whole organ decellularization processes
2011 Standout
CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis†
2009
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Pre- and Post-Transplant Antiviral Therapy (HBV, HCV)
2016
Biological modulation of renal ischemia–reperfusion injury
2010
Cryoglobulinemia and renal disease
2008
Portal hypertensive bleeding in cirrhosis
2016 Standout
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Peginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis C
2009
Evolving challenges in hepatic fibrosis
2010
Mechanisms of Hepatic Fibrogenesis
2008 Standout
An artificial liver sinusoid with a microfluidic endothelial‐like barrier for primary hepatocyte culture
2007
Microfluidic organs-on-chips
2014 Standout
Resection for Hilar Cholangiocarcinoma: Analysis of Prognostic Factors and the Impact of Systemic Inflammation on Long-term Outcome
2013
Global burden of liver disease: 2023 update
2023 Standout
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Introduction to the revised American Association for the Study of Liver Diseases position paper on acute liver failure 2011
2011
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
2016
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
Capturing complex 3D tissue physiology in vitro
2006 Standout
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
2006
Infection in Solid-Organ Transplant Recipients
2007 Standout
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
The role of the microcirculation in acute kidney injury
2009
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Tacrolimus-Associated Posterior Reversible Encephalopathy Syndrome after Solid Organ Transplantation
2010
+49A/G polymorphism of cytotoxic T‐lymphocyte antigen 4 gene in type 1 autoimmune hepatitis and primary biliary cirrhosis: A meta‐analysis
2011
Replication of hepatitis C virus
2007 StandoutNobel
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Internal Initiation Stimulates Production of p8 Minicore, a Member of a Newly Discovered Family of Hepatitis C Virus Core Protein Isoforms
2009 StandoutNobel
The HCV IRES pseudoknot positions the initiation codon on the 40S ribosomal subunit
2010 StandoutNobel
Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation
2016
Interferon-Free Regimens in the Liver-Transplant Setting
2014
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype
2012
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Inflammatory responses and inflammation-associated diseases in organs
2017 Standout
Accurate Prediction of Drug-Induced Liver Injury Using Stem Cell-Derived Populations
2013
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Living donor liver transplantation in Europe.
2016
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents
2014 StandoutNobel
Innate immunity in alcoholic liver disease
2011
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta‐analysis
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Hepatocellular Carcinoma in 2 Young Adolescents With Chronic Hepatitis C
2009
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
2009
Works of Gero Puhl being referenced
Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up
2004
Patient and tumour biology predict survival beyond the Milan criteria in liver transplantation for hepatocellular carcinoma
2014
In vivo Visualization of Early Microcirculatory Changes following Ischemia/Reperfusion Injury in Human Kidney Transplantation
2007
No Role of Matrixmetalloproteinase‐3 Genetic Promoter Polymorphism 1171 as a Risk Factor for Cirrhosis in Alcoholic Liver Disease
2008
MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course
2005
Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection
2006
A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection
2007
The Marburg I variant (G534E) of the factor VII–activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet‐derived growth factor BB†
2008
Long‐term follow‐up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients
2006
Clinical extracorporeal hybrid liver support – phase I study with primary porcine liver cells
2003
The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers
2010
Low viscosity histidine-tryptophan-ketoglutarate graft flush improves subsequent extended cold storage in University of Wisconsin solution in an extracorporeal rat liver perfusion and rat liver transplantation model
2006
CT-guided Interstitial Brachytherapy of Hepatocellular Carcinoma before Liver Transplantation: an Equivalent Alternative to Transarterial Chemoembolization?
2015
Association of TLR7 single nucleotide polymorphisms with chronic HCV‐infection and response to interferon‐a‐based therapy
2007
Living donor liver transplantation in adults in the MELD era in Germany - a multi-center retrospective analysis
2011
Donor Age Does Not Influence 12-Month Outcome After Orthotopic Liver Transplantation
2011
Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease
2007
Oncological Superiority of Hilar En Bloc Resection for the Treatment of Hilar Cholangiocarcinoma
2011
Treatment of Patients with Recurrent Hepatitis C after Liver Transplantation with Peginterferon Alfa-2B Plus Ribavirin
2006
Biliary Reconstruction Using a Side-to-Side Choledochocholedochostomy With or Without T-Tube in Deceased Donor Liver Transplantation
2009
Twenty-Year Longitudinal Follow-Up After Orthotopic Liver Transplantation: A Single-Center Experience of 313 Consecutive Cases
2013
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection
2008
Noninvasive in vivo analysis of the human hepatic microcirculation using orthogonal polorization spectral imaging
2003
Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.
2007
Chemokine receptor 5Delta32 mutation reduces the risk of acute rejection in liver transplantation.
2009
Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
2009
Impact of neoadjuvant transarterial chemoembolization on tumor recurrence and patient survival after liver transplantation for hepatocellular carcinoma: a retrospective analysis
2012